12.07.2015 Views

Measles, Mumps, and Rubella - Centers for Disease Control and ...

Measles, Mumps, and Rubella - Centers for Disease Control and ...

Measles, Mumps, and Rubella - Centers for Disease Control and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Vol. 47 / No. RR-8 MMWR 39• is not epidemiologically linked to a confirmed case, <strong>and</strong>• has not been serologically or virologically tested or has noncontributory serologicor virologic results.A confirmed case of measles• meets the laboratory criteria <strong>for</strong> measles or• meets the clinical case definition <strong>and</strong> is epidemiologically linked to a confirmedcase.Confirmed measles cases are routinely reported to CDC by state health departments.Laboratory DiagnosisThe laboratory criteria <strong>for</strong> measles diagnosis are:• a positive serologic test <strong>for</strong> measles IgM antibody, or• a significant rise in measles antibody level by any st<strong>and</strong>ard serologic assay, or• isolation of measles virus from a clinical specimen.A laboratory-confirmed case need not meet the clinical case definition. Serologicconfirmation should be attempted <strong>for</strong> every suspected case of measles <strong>and</strong> is particularlyimportant <strong>for</strong> any case that cannot be epidemiologically linked through a chain oftransmission to a confirmed case. However, reporting of suspected or probable cases,investigation of cases, <strong>and</strong> the implementation of control activities should not be delayedpending laboratory results.Blood <strong>for</strong> serologic testing should be collected during the first clinical encounterwith a person who has suspected or probable measles. The serum should be tested<strong>for</strong> measles IgM antibody as soon as possible using an assay that is both sensitive <strong>and</strong>specific (e.g., direct-capture IgM EIA method). Correct interpretation of serologic datadepends on the timing of specimen collection in relation to rash onset <strong>and</strong> on thecharacteristics of the antibody assay used. This timing is especially important <strong>for</strong> interpretingnegative results because IgM antibody may not be detectable with someless sensitive assays until at least 72 hours after rash onset. <strong>Measles</strong> IgM may be detectableat the time of rash onset, peaks approximately 10 days after rash onset, <strong>and</strong>is usually undetectable 30–60 days after rash onset. In general, if measles IgM is notdetected in a serum specimen obtained in the first 72 hours after rash onset from aperson whose illness meets the clinical case definition <strong>for</strong> measles, another specimenshould be obtained at least 72 hours after rash onset <strong>and</strong> tested <strong>for</strong> measles IgM antibody.<strong>Measles</strong> IgM is detectable <strong>for</strong> at least 1 month after rash onset. Persons withfebrile rash illnesses who are seronegative <strong>for</strong> measles should be tested <strong>for</strong> rubella.As measles becomes rare in the United States, the likelihood of obtaining falsepositive serologic results from measles IgM antibody testing increases. False positiveresults have been obtained by using a commercially available ELISA assay <strong>for</strong> measlesIgM in persons with parvovirus infection (fifth disease) (224 ). Confirmatorytesting by using an assay that is both sensitive <strong>and</strong> specific (e.g., direct-capture IgMEIA method) should be considered when IgM is detected in a patient with suspected

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!